TP53 and cardiac hypertrophy: The major findings of this study are as follows: (a) PI16 decreases CF proliferation and Ang II–induced fibrotic marker protein expression by regulating HDAC1/p53 signalling; (b) highly expressed PI16 in CFs attenuates cardiac hypertrophy and fibrosis induced by Ang II.